- Home
- SCNX vs BNGO Comparison
SCNX vs BNGO Comparison
Compare SCNX & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNX
- BNGO
- Stock Information
- Founded
- SCNX 2010
- BNGO 2003
- Country
- SCNX United States
- BNGO United States
- Employees
- SCNX N/A
- BNGO N/A
- Industry
- SCNX Other Pharmaceuticals
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- SCNX Health Care
- BNGO Industrials
- Exchange
- SCNX Nasdaq
- BNGO Nasdaq
- Market Cap
- SCNX 21.2M
- BNGO 24.3M
- IPO Year
- SCNX 2020
- BNGO 2018
- Fundamental
- Price
- SCNX $1.21
- BNGO $3.04
- Analyst Decision
- SCNX
- BNGO Buy
- Analyst Count
- SCNX 0
- BNGO 5
- Target Price
- SCNX N/A
- BNGO $7.33
- AVG Volume (30 Days)
- SCNX 330.0K
- BNGO 110.7K
- Earning Date
- SCNX 08-12-2025
- BNGO 08-14-2025
- Dividend Yield
- SCNX N/A
- BNGO N/A
- EPS Growth
- SCNX N/A
- BNGO N/A
- EPS
- SCNX N/A
- BNGO N/A
- Revenue
- SCNX $128,202.00
- BNGO $27,426,000.00
- Revenue This Year
- SCNX N/A
- BNGO N/A
- Revenue Next Year
- SCNX N/A
- BNGO $15.54
- P/E Ratio
- SCNX N/A
- BNGO N/A
- Revenue Growth
- SCNX N/A
- BNGO N/A
- 52 Week Low
- SCNX $0.69
- BNGO $2.68
- 52 Week High
- SCNX $10.23
- BNGO $37.09
- Technical
- Relative Strength Index (RSI)
- SCNX N/A
- BNGO 42.36
- Support Level
- SCNX N/A
- BNGO $2.92
- Resistance Level
- SCNX N/A
- BNGO $3.33
- Average True Range (ATR)
- SCNX 0.00
- BNGO 0.16
- MACD
- SCNX 0.00
- BNGO 0.02
- Stochastic Oscillator
- SCNX 0.00
- BNGO 33.33
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.